Investor Alert

press release

Sept. 2, 2022, 6:30 a.m. EDT

Sage Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference

CAMBRIDGE, Mass., (BUSINESS WIRE) -- Sage Therapeutics, Inc. /zigman2/quotes/200179567/composite SAGE +0.91% , a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 3:40 p.m. ET in New York, NY.

A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com . A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20220902005053/en/

SOURCE: Sage Therapeutics, Inc.

Helen Rubinstein

Becky Kern


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2022

US : U.S.: Nasdaq
$ 37.79
+0.34 +0.91%
Volume: 123,095
Nov. 25, 2022 1:00p
P/E Ratio
Dividend Yield
Market Cap
$2.25 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.